改善肿瘤患者与照护者结局:基于团队、及时且靶向的姑息治疗
本文综述支持将姑息治疗整合入晚期肿瘤实践的当代文献,提出基于团队、及时和靶向的姑息治疗概念模型,并总结门诊、嵌入式门诊、护士主导、肿瘤团队提供初级姑息治疗及自动转诊等创新模式的优势与不足,指出需更多研究确定不同卫生系统如何最佳个体化姑息治疗。
要点
- 基于团队的姑息治疗由跨学科成员全面处理患者及照护者的多维需求。
- 及时的姑息治疗最佳形式为预防性照护,以减少生命末期的危机。
- 靶向姑息治疗识别最可能从专科姑息治疗干预中获益的患者。
核心结论
- 姑息治疗应整合入晚期肿瘤实践,问题已非是否提供,而是最佳提供模式、理想转诊时机、最需转诊人群及肿瘤医生自身应提供多少姑息治疗。
研究设计与样本
- 面向执业肿瘤临床医生的现状科学综述,讨论当代文献中专科姑息治疗对各健康结局的影响,并提供概念模型及创新照护模式优缺点的总结。
主要发现
- 基于团队的姑息治疗使跨学科成员能全面处理患者及照护者的多维照护需求。
- 及时的姑息治疗最佳形式为预防性照护,以尽量减少生命末期的危机。
- 靶向姑息治疗涉及识别最可能从专科姑息治疗干预中获益的患者,类似于靶向肿瘤治疗的概念。
- 综述总结了门诊诊所、嵌入式诊所、护士主导的姑息治疗、肿瘤团队提供的初级姑息治疗及自动转诊等创新照护模式的优势与不足。
关键数值与推荐
- 基于团队的姑息治疗:跨学科成员全面处理患者及照护者的多维照护需求。
- 及时的姑息治疗:最佳形式为预防性照护,以尽量减少生命末期的危机。
- 靶向的姑息治疗:识别最可能从专科姑息治疗干预中获益的患者,类似于靶向肿瘤治疗的概念。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更多研究来确定不同卫生系统如何最佳地个体化姑息治疗,以便在正确的时间、正确的环境下为正确的患者提供正确水平的干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past decade, a large body of evidence has accumulated supporting the integration of palliative care into oncology practice for patients with advanced cancer. The question is no longer whether palliative care should be offered, but what is the optimal model of delivery, when is the ideal time to refer, who is in greatest need of a referral, and how much palliative care should oncologists themselves be providing. These questions are particularly relevant given the scarcity of palliative care resources internationally. In this state-of-the-science review directed at the practicing cancer clinician, the authors first discuss the contemporary literature examining the impact of specialist palliative care on various health outcomes. Then, conceptual models are provided to support team-based, timely, and targeted palliative care. Team-based palliative care allows the interdisciplinary members to address comprehensively the multidimensional care needs of patients and their caregivers. Timely palliative care, at its best, is preventive care to minimize crises at the end of life. Targeted palliative care involves identifying the patients most likely to benefit from specialist palliative care interventions, akin to the concept of targeted cancer therapies. Finally, the strengths and weaknesses of innovative care models, such as outpatient clinics, embedded clinics, nurse-led palliative care, primary palliative care provided by oncology teams, and automatic referral, are summarized. Moving forward, more research is needed to determine how different health systems can best personalize palliative care to provide the right level of intervention, for the right patient, in the right setting, at the right time. CA Cancer J Clin. 2018;680:00-00. 2018 American Cancer Society, Inc.
引用
- Hui D, Hannon BL, Zimmermann C, et al. Improving patient and caregiver outcomes in oncology: Team-based, timely, and targeted palliative care. CA Cancer J Clin. 2018. PMID: 30277572. doi:10.3322/caac.21490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。